|
European Parliament Endorses Premarket Controls for Riskiest Medical Devices
The EU is one step closer to mandating premarket authorization for Class IIb and Class III medical devices, following the European Parliament’s adoption of proposals aimed at beefing up device regulation in the wake of the PIP silicone gel breast implant scandal.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
IMDRF Unveils Global UDI Scheme; Core Concepts Endorsed in EU RecommendationUDI Takes Two Steps Forward With IMDRF Guidance, EU Recommendations on SchemeCentralized Premarket Mechanism Is Not Answer to EU Device Regulation: IndustryEuropean Commission Seeks Comment on Regulation of Advanced Therapies
|
Subscribe
Archives